发明名称 COMBINATION OF AN ACE INHIBITOR, A CALCIUM CHANNEL BLOCKER AND A DIURETIC
摘要 The present invention relates to a method of treatment of a condition or disease selected from the group consisting of hypertension, left ventricular dysfunction and hypertrophic cardiomyopathy, diabetic cardiac myopahty, supraventricular and ventricular arrhythmias, atrial fibrillation, atrial flutter, detrimental vascular remodeling, myocardial infarction and its sequelae, antheroscleorosis, angina (whether unstable or stable), renal insufficiency (diabetic and non-diabetic), heart failure, angina pectoris, diabetes, secondary aldosteronism, primary and secondary pulmonary hypertension, renal failure conditions, such as diabetic nephropathy, glomerulonephritis, scleroderma, glomecular sclerosis, proteinuria of primary renal disease,and also renal vascular hypertension, diabetic retinophathy, the management of other vascular disorders, such as migraine, peripheral vascular disease, Raynaud´s disease, luminal hyperplasia, endothelial dysfunction, cognitive dysfunction( such as Alzheimer's), glaucoma and stroke, comprising administering, to a mammal in need thereof, a therapeutically effective amount of a combination comprising (i) an ACE inhibitor, (ii) a calcium channel blocker (CCB), and (iii) a diuretic.
申请公布号 WO03097067(A1) 申请公布日期 2003.11.27
申请号 WO2003EP05195 申请日期 2003.05.16
申请人 NOVARTIS AG.;NOVARTIS PHARMA GMBH;GRIGORIEFF, MELISSA;SHETTY, SURAJ, SHIVAPPA;WEBB, RANDY, LEE 发明人 GRIGORIEFF, MELISSA;SHETTY, SURAJ, SHIVAPPA;WEBB, RANDY, LEE
分类号 A61K45/06;A61K31/4422;A61K31/455;A61K31/549;A61K31/55;A61P3/10;A61P5/42;A61P7/10;A61P9/00;A61P9/04;A61P9/06;A61P9/10;A61P9/12;A61P9/14;A61P13/02;A61P13/12;A61P17/00;A61P25/06;A61P25/28;A61P27/06;A61P43/00;(IPC1-7):A61K31/55;A61K31/442 主分类号 A61K45/06
代理机构 代理人
主权项
地址